Cell Transdifferentiation via HB-EGF and ADAM 12 Expression

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods fail to effectively convert cells into brown adipose tissue cells, which are crucial for treating obesity and cancer, as they do not exhibit significant cell proliferation but rather convert cells into brown adipose tissue cells unexpectedly.

Innovation Solution

Transforming animal cells using an expression vector that includes a nucleotide sequence encoding HB-EGF operatively linked to a promoter and a nucleotide sequence encoding ADAM 12 operatively linked to a promoter, allowing for the transdifferentiation of cells into brown adipose tissue cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If cells are transformed to express HB-EGF and ADAM 12, then cell conversion to brown adipose tissue is achieved, but cell proliferation is not stimulated as expected

Engineering Contradiction:

Improvecell conversion efficiencyVSAvoidcell proliferation

Core Design Contradiction:

ReliabilityVSProductivity

Solution Approach 1:

The invention changes the functional parameters of the cells by introducing specific gene expressions (HB-EGF and ADAM 12) that alter the cell's differentiation pathway. This parameter change redirects cell fate from proliferation to transdifferentiation into brown adipose tissue, resolving the contradiction between expected proliferation and actual conversion efficiency.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

ADAM 12 acts as an intermediary enzyme that processes membrane-bound HB-EGF to release soluble HB-EGF. This intermediary mechanism creates a specific signaling cascade that drives brown adipose tissue differentiation rather than general cell proliferation, achieving reliable cell conversion with a defined molecular pathway.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If ADAM 12S is used to process HB-EGF, then brown adipose tissue formation is stimulated, but uncontrolled cell proliferation is avoided

Engineering Contradiction:

Improveadipogenesis controlVSAvoiduncontrolled cell proliferation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention converts the potential harmful effect of uncontrolled cell proliferation into a beneficial outcome by using ADAM 12S-mediated HB-EGF processing to drive controlled differentiation. The same molecular pathway that could potentially cause proliferation is instead harnessed to promote organized brown adipose tissue formation, turning a potential risk into a therapeutic benefit for obesity treatment.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method successfully converts cells into brown adipose tissue cells, which can be used to treat obesity by increasing metabolism and potentially treat cancer by altering cell proliferation and differentiation pathways.

Implementation Method 1

ADAM 12S stimulates ectodomain shedding of pro-HB-EGF, releasing a mature, soluble ligand (sHB-EGF) and a carboxyl-terminal fragment (HB-EGF-C)

Methodology Applied

Scientific EffectProteolytic processing: Hydrolysis

Data Source

PatentUS8835112B2Cell transdifferentiation into brown adipocytes

Publication Date: 2014.09.16 UNIV OF MIAMI

AI summary

A method for converting animal cells into brown adipose tissue cells is provided that includes transforming the animal cells using an expression vector. The expression vector includes a nucleotide sequence encoding HB-EGF operatively linked to a promoter and a nucleotide sequence encoding ADAM 12 operatively linked to a promoter. Converting animal cells to brown adipose tissue cells can be used to treat obesity or to treat cancer by converting target cells to brown adipose tissue cells.